Last 12 months
Inside the activity.
0 purchase rows · 0 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 0 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 28, 2024 Filed Jul 3, 2024 01:53 UTC |
Venkatesan JayDirector
|
PurchasePre-Funded Warrants · Derivative | 50,000 | $4.99 Strike: $0.01 | $249,500.00 |
DisclosureSEC source: 0001140361-24-032293 · form4.xml · derivative · entry 8 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date. F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 01:53 UTC |
Venkatesan JayDirector
|
PurchaseCommon Warrants · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001140361-24-032293 · form4.xml · derivative · entry 7 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029. F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 01:53 UTC |
Venkatesan JayDirector
|
PurchasePre-Funded Warrants · Derivative | 50,000 | $4.99 Strike: $0.01 | $249,500.00 |
DisclosureSEC source: 0001140361-24-032293 · form4.xml · derivative · entry 6 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date. F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 01:53 UTC |
Venkatesan JayDirector
|
PurchaseCommon Warrants · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001140361-24-032293 · form4.xml · derivative · entry 5 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029. F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 01:53 UTC |
Venkatesan JayDirector
|
PurchasePre-Funded Warrants · Derivative | 50,000 | $4.99 Strike: $0.01 | $249,500.00 |
DisclosureSEC source: 0001140361-24-032293 · form4.xml · derivative · entry 4 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date. F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 01:53 UTC |
Venkatesan JayDirector
|
PurchaseCommon Warrants · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001140361-24-032293 · form4.xml · derivative · entry 3 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Indirect · See footnote Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029. F5 · ownership.nature: The Reporting Person may be deemed to have shared voting and investment power over the trust which holds these securities. A Member of the Reporting Person's immediate family is the beneficiary of the trust which holds these securities. The Reporting Person disclaims beneficial ownership of the securities held by the trust which holds these securities except to the extent of his pecuniary interest therein, if any. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 01:53 UTC |
Venkatesan JayDirector
|
PurchasePre-Funded Warrants · Derivative | 50,000 | $4.99 Strike: $0.01 | $249,500.00 |
DisclosureSEC source: 0001140361-24-032293 · form4.xml · derivative · entry 2 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date. Read SEC document |
| June 28, 2024 Filed Jul 3, 2024 01:53 UTC |
Venkatesan JayDirector
|
PurchaseCommon Warrants · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001140361-24-032293 · form4.xml · derivative · entry 1 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:30 UTC |
Chudnovsky YekaterinaDirector · 10% owner
GKCC, LLC10% owner
|
PurchasePre-Funded Warrants · Derivative | 1,600,000 | $4.99 Strike: $0.01 | $7,984,000.00 |
DisclosureSEC source: 0001140361-24-032163 · form4.xml · derivative · entry 2 Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner GKCC, LLC · CIK 0001977769 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600,000 Underlying: Common Stock · 1,600,000 shares Expires not disclosed F3 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%. F4 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date. Read SEC document |
| June 28, 2024 Filed Jul 2, 2024 20:30 UTC |
Chudnovsky YekaterinaDirector · 10% owner
GKCC, LLC10% owner
|
PurchaseCommon Warrants · Derivative | 1,600,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001140361-24-032163 · form4.xml · derivative · entry 1 Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner GKCC, LLC · CIK 0001977769 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 1,600,000 Underlying: Common Stock · 1,600,000 shares Expires not disclosed F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%. F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029. Read SEC document |
| June 28, 2024 Filed Jan 2, 2025 21:05 UTC Amendment |
Venkatesan JayDirector
|
PurchasePre-Funded Warrants · Derivative | 50,000 | $4.99 Strike: $0.01 | $249,500.00 |
DisclosureSEC source: 0001601485-25-000002 · wk-form4a_1735851944.xml · derivative · entry 2 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F4 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F5 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date. F3 · ownership.direct: On July 2, 2024, the Reporting Person mistakenly filed a Form 4 reporting the acquisition of an additional 150,000 Common Warrants and 150,000 Pre-Funded Warrants. The Reporting Person is not the beneficial owner of such Common Warrants or Pre-Funded Warrants. As of January 2, 2025, the Reporting Person owned only the Common Warrants and Pre-Funded Warrants reported herein. Read SEC document |
| June 28, 2024 Filed Jan 2, 2025 21:05 UTC Amendment |
Venkatesan JayDirector
|
PurchaseCommon Warrants · Derivative | 50,000 | $0.00 Strike: $5.00 | $0.00 |
DisclosureSEC source: 0001601485-25-000002 · wk-form4a_1735851944.xml · derivative · entry 1 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires not disclosed F1 · derivative.exercise_date: Each Common Warrant will be exercisable by the holder at any time on or after July 1, 2024 at an exercise price equal to $5.00 per share, subject to adjustments as provided under the terms of the Common Warrant, subject to a post-exercise beneficial ownership limitation of 4.99%. F2 · derivative.expiration_date: The Common Warrants expire on July 1, 2029. F3 · ownership.direct: On July 2, 2024, the Reporting Person mistakenly filed a Form 4 reporting the acquisition of an additional 150,000 Common Warrants and 150,000 Pre-Funded Warrants. The Reporting Person is not the beneficial owner of such Common Warrants or Pre-Funded Warrants. As of January 2, 2025, the Reporting Person owned only the Common Warrants and Pre-Funded Warrants reported herein. Read SEC document |
| March 19, 2024 Filed Mar 20, 2024 20:28 UTC |
Chudnovsky YekaterinaDirector · 10% owner
GKCC, LLC10% owner
|
PurchasePre-Funded Common Stock Purchase Warrant · Derivative | 1,032,702 | $5.81 Strike: $0.01 | $5,999,998.62 |
DisclosureSEC source: 0000950170-24-034198 · ownership.xml · derivative · entry 1 Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner GKCC, LLC · CIK 0001977769 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by GKCC, LLC Disclosed balance after: 1,032,702 Underlying: Common Stock · 1,032,702 shares Expires not disclosed F1 · derivative.exercise_date: Each Pre-Funded Warrant will be exercisable by GKCC, LLC at any time on or after March 19, 2024 at an exercise price equal to $0.01 per share, subject to adjustments as provided under the terms of the Pre-Funded Warrant, subject to a post-exercise beneficial ownership limitation of 19.99%, unless stockholder approval is obtained. F2 · derivative.expiration_date: The Pre-Funded Warrants do not have an expiration date. F3 · ownership.nature: Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 11:01 UTC |
Piekos BrianChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 43,225 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001140361-24-005499 · form4.xml · derivative · entry 1 Piekos Brian · CIK 0001815308 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 43,225 Underlying: Common Stock · 43,225 shares Expires 2034-02-01 F1 · derivative.exercise_date: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 11:01 UTC |
Haqq ChristopherSee Remarks
|
GrantStock Option (right to buy) · Derivative | 28,200 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001140361-24-005497 · form4.xml · derivative · entry 1 Haqq Christopher · CIK 0001612095 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 28,200 Underlying: Common Stock · 28,200 shares Expires 2034-02-01 F1 · derivative.exercise_date: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 11:01 UTC |
Connelly RobertDirector · CEO, President and Director
|
GrantStock Option (right to buy) · Derivative | 225,137 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001140361-24-005498 · form4.xml · derivative · entry 1 Connelly Robert · CIK 0001796436 · Director · CEO, President and Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 225,137 Underlying: Common Stock · 225,137 shares Expires 2034-02-01 F1 · derivative.exercise_date: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 11:01 UTC |
DeMuth PeterChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 342 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001140361-24-005496 · form4.xml · derivative · entry 2 DeMuth Peter · CIK 0001979163 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 342 Underlying: Common Stock · 342 shares Expires 2034-02-01 F2 · derivative.exercise_date: The stock options vested in full on February 1, 2024. Read SEC document |
| February 01, 2024 Filed Feb 5, 2024 11:01 UTC |
DeMuth PeterChief Scientific Officer
|
GrantStock Option (right to buy) · Derivative | 29,800 | $0.00 Strike: $4.50 | $0.00 |
DisclosureSEC source: 0001140361-24-005496 · form4.xml · derivative · entry 1 DeMuth Peter · CIK 0001979163 · Chief Scientific Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 29,800 Underlying: Common Stock · 29,800 shares Expires 2034-02-01 F1 · derivative.exercise_date: Twenty five percent (25%) of the stock options vest on February 1, 2025, the one-year anniversary of the grant date, with the remaining options vesting in monthly installments over a three-year period thereafter, subject to the Reporting Person's continued service to the Issuer through the applicable vesting dates. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 17:05 UTC |
Ashe Carol GailDirector
|
GrantStock Option (right to buy) · Derivative | 4,100 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001140361-23-060236 · form4.xml · derivative · entry 1 Ashe Carol Gail · CIK 0001761748 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2033-12-28 F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:05 UTC |
Nissenson AllenDirector
|
GrantStock Option (right to buy) · Derivative | 4,100 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001140361-23-060239 · form4.xml · derivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2033-12-28 F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:05 UTC |
Venkatesan JayDirector
|
GrantStock Option (right to buy) · Derivative | 4,100 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001140361-23-060235 · form4.xml · derivative · entry 1 Venkatesan Jay · CIK 0001413350 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2033-12-28 F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:05 UTC |
WILSON KAREN JDirector
|
GrantStock Option (right to buy) · Derivative | 4,100 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001140361-23-060237 · form4.xml · derivative · entry 1 WILSON KAREN J · CIK 0001267490 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2033-12-28 F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:05 UTC |
RUFFOLO ROBERT RDirector
|
GrantStock Option (right to buy) · Derivative | 4,100 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001140361-23-060233 · form4.xml · derivative · entry 1 RUFFOLO ROBERT R · CIK 0001187308 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2033-12-28 F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 17:05 UTC |
ADAMS JULIANDirector
|
GrantStock Option (right to buy) · Derivative | 4,100 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001140361-23-060234 · form4.xml · derivative · entry 1 ADAMS JULIAN · CIK 0001230486 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2033-12-28 F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| December 28, 2023 Filed Dec 29, 2023 22:05 UTC |
Chudnovsky YekaterinaDirector · 10% owner
|
GrantStock Option (right to buy) · Derivative | 4,100 | $0.00 Strike: $8.26 | $0.00 |
DisclosureSEC source: 0001140361-23-060238 · form4.xml · derivative · entry 1 Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 4,100 Underlying: Common Stock · 4,100 shares Expires 2033-12-28 F1 · shares: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. F1 · derivative.exercise_date: The stock option, granted in lieu of the annual equity award under the Issuer's Amended and Restated Non-Employee Director Compensation Policy, vests in full on the earlier of (A) December 28, 2024, the one-year anniversary of the grant date, or (B) immediately prior to the next annual meeting of the Issuer's stockholders, subject to the Reporting Person continuing to provide services to the Issuer through such vesting date. Read SEC document |
| December 22, 2023 Filed Dec 26, 2023 21:29 UTC |
Chudnovsky YekaterinaDirector · 10% owner
GKCC, LLC10% owner
|
PurchaseCommon Stock | 1,213,000 | $5.81 | $7,047,530.00 |
DisclosureSEC source: 0001209191-23-059683 · doc4.xml · nonDerivative · entry 1 Chudnovsky Yekaterina · CIK 0001979324 · Director · 10% owner GKCC, LLC · CIK 0001977769 · 10% owner Joint disclosure: these amounts are not allocated separately to each reporting owner. 10b5-1 filing: No plan indicated Ownership: Indirect · Held by GKCC, LLC Disclosed balance after: 1,915,639 F1 · ownership.nature: Yekaterina (Katie) Chudnovsky is the sole member and manager of GKCC, LLC and may be deemed to beneficially own the shares held by GKCC, LLC. Read SEC document |
| June 01, 2023 Filed Jun 5, 2023 21:25 UTC |
Piekos BrianChief Financial Officer
|
GrantStock Option (right to buy) · Derivative | 75,484 | $0.00 Strike: $10.00 | $0.00 |
DisclosureSEC source: 0001140361-23-028420 · form4.xml · derivative · entry 1 Piekos Brian · CIK 0001815308 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 75,484 Underlying: Common Stock · 75,484 shares Expires 2033-06-01 F1 · derivative.exercise_date: The option vests as to 25% of the option shares on May 15, 2024 with the remainder vesting in 36 equal monthly installments at the end of each month thereafter, subject to the Reporting Person continuing to provide services to the Issuer through the applicable vesting dates, and provided that in the event there is a change in control of the Issuer, followed by a subsequent termination of the Reporting Person's employment without cause (or a material diminishment of his role) within 12 months of the change of control, any unvested options granted will immediately vest. Read SEC document |
| July 01, 2022 Filed Jul 11, 2022 19:54 UTC |
Goldberg ItzhakDirector
|
Tax withholdingCommon Stock | 32,082 | $1.12 | $35,931.84 |
DisclosureSEC source: 0001601485-22-000059 · wf-form4_165758365151556.xml · nonDerivative · entry 1 Goldberg Itzhak · CIK 0001607858 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,687,986 F1 · kind: The shares were withheld to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Units ("RSUs"). Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 21:26 UTC |
Nissenson AllenDirector
|
GrantCommon Stock · Derivative | 15,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001601485-22-000052 · wf-form4_165515558808558.xml · derivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 21:26 UTC |
WILSON KAREN JDirector
|
GrantCommon Stock · Derivative | 15,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001601485-22-000051 · wf-form4_165515557133787.xml · derivative · entry 1 WILSON KAREN J · CIK 0001267490 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 21:26 UTC |
OMENN GILBERT SDirector
|
GrantCommon Stock · Derivative | 15,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001601485-22-000050 · wf-form4_165515555115849.xml · derivative · entry 1 OMENN GILBERT S · CIK 0001184227 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| June 09, 2022 Filed Jun 13, 2022 17:27 UTC |
GANZI VICTOR FDirector
|
GrantCommon Stock · Derivative | 15,000 | $0.00 Strike: $1.73 | $0.00 |
DisclosureSEC source: 0001601485-22-000053 · wf-form4_165515561728971.xml · derivative · entry 1 GANZI VICTOR F · CIK 0001199070 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 15,000 Underlying: Common Stock · 15,000 shares Expires 2032-06-09 F1 · derivative.exercise_date: 1.To vest on the earlier of the first anniversary of the date of grant or the date of the next annual stockholder's meeting to the extent unvested as of such date, subject to continued service through each applicable vesting date. Read SEC document |
| May 25, 2022 Filed May 27, 2022 20:18 UTC |
Venkatesan JayDirector · See Remarks
|
PurchaseCommon Stock | 11,313 | $1.25 | $14,102.79 |
DisclosureSEC source: 0001601485-22-000043 · wf-form4_165368268236817.xml · nonDerivative · entry 1 Venkatesan Jay · CIK 0001413350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,891,947 Read SEC document |
| May 24, 2022 Filed May 25, 2022 21:58 UTC |
Venkatesan JayDirector · See Remarks
|
PurchaseCommon Stock | 32,200 | $1.24 | $39,928.00 |
DisclosureSEC source: 0001601485-22-000039 · wf-form4_165351588830337.xml · nonDerivative · entry 2 Venkatesan Jay · CIK 0001413350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,721,457 Read SEC document |
| May 20, 2022 Filed May 23, 2022 23:48 UTC |
Nissenson AllenDirector
|
PurchaseCommon Stock | 2,037 | $1.18 | $2,403.66 |
DisclosureSEC source: 0001628280-22-015238 · wf-form4_165334970201347.xml · nonDerivative · entry 2 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,383 Read SEC document |
| May 20, 2022 Filed May 25, 2022 21:58 UTC |
Venkatesan JayDirector · See Remarks
|
PurchaseCommon Stock | 50,000 | $1.23 | $61,500.00 |
DisclosureSEC source: 0001601485-22-000039 · wf-form4_165351588830337.xml · nonDerivative · entry 1 Venkatesan Jay · CIK 0001413350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,689,257 Read SEC document |
| May 19, 2022 Filed May 23, 2022 23:48 UTC |
Nissenson AllenDirector
|
PurchaseCommon Stock | 7,346 | $1.16 | $8,521.36 |
DisclosureSEC source: 0001628280-22-015238 · wf-form4_165334970201347.xml · nonDerivative · entry 1 Nissenson Allen · CIK 0001441889 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,346 F1 · price: The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $1.14 to $1.18 inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 21:22 UTC |
Venkatesan JaySee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 160,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001601485-22-000014 · wf-form4_164642894442998.xml · derivative · entry 2 Venkatesan Jay · CIK 0001413350 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 760,000 Underlying: Common Stock · 160,000 shares Expires 2032-03-02 F2 · derivative.exercise_date: The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022. Read SEC document |
| March 03, 2022 Filed Mar 4, 2022 21:22 UTC |
Venkatesan JaySee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 600,000 | $0.00 Strike: $1.94 | $0.00 |
DisclosureSEC source: 0001601485-22-000014 · wf-form4_164642894442998.xml · derivative · entry 1 Venkatesan Jay · CIK 0001413350 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 600,000 Underlying: Common Stock · 600,000 shares Expires 2032-03-02 F1 · derivative.exercise_date: The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 16:21 UTC |
Neylan John F.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001601485-22-000013 · wf-form4_164642889806390.xml · derivative · entry 2 Neylan John F. · CIK 0001640447 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 100,000 shares Expires 2032-03-01 F2 · derivative.exercise_date: The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 16:21 UTC |
Neylan John F.See Remarks
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001601485-22-000013 · wf-form4_164642889806390.xml · derivative · entry 1 Neylan John F. · CIK 0001640447 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 21:20 UTC |
CURHAN GREGORY SSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001601485-22-000011 · wf-form4_164642880552681.xml · derivative · entry 1 CURHAN GREGORY S · CIK 0001263244 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 100,000 Underlying: Common Stock · 100,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 16:21 UTC |
Rhodes Jennifer JSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 100,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001601485-22-000012 · wf-form4_164642885246988.xml · derivative · entry 2 Rhodes Jennifer J · CIK 0001568249 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 275,000 Underlying: Common Stock · 100,000 shares Expires 2032-03-01 F2 · derivative.exercise_date: The total number of options vest in equal parts on July 31, 2022 and December 31, 2022, such that 100% of the options will be fully vested and exercisable on December 31, 2022. Read SEC document |
| March 02, 2022 Filed Mar 4, 2022 16:21 UTC |
Rhodes Jennifer JSee Remarks
|
GrantStock Option (Right to Buy) · Derivative | 175,000 | $0.00 Strike: $1.99 | $0.00 |
DisclosureSEC source: 0001601485-22-000012 · wf-form4_164642885246988.xml · derivative · entry 1 Rhodes Jennifer J · CIK 0001568249 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,000 Underlying: Common Stock · 175,000 shares Expires 2032-03-01 F1 · derivative.exercise_date: The total number of options vest in forty-eight (48) successive and equal monthly installments as measured from March 3, 2022 (the "Vesting Commencement Date"), such that 100% of the options will be fully vested and exercisable on the fourth anniversary of the Vesting Commencement Date. Read SEC document |
| December 28, 2021 Filed Dec 29, 2021 21:08 UTC |
Venkatesan JayDirector · See Remarks
|
PurchaseCommon Stock | 210,337 | $2.66 | $559,853.99 |
DisclosureSEC source: 0001601485-21-000095 · wf-form4_164081206871822.xml · nonDerivative · entry 2 Venkatesan Jay · CIK 0001413350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,639,257 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.55 to $2.75 inclusive. Read SEC document |
| December 27, 2021 Filed Dec 29, 2021 21:08 UTC |
Venkatesan JayDirector · See Remarks
|
PurchaseCommon Stock | 66,907 | $2.55 | $170,519.18 |
DisclosureSEC source: 0001601485-21-000095 · wf-form4_164081206871822.xml · nonDerivative · entry 1 Venkatesan Jay · CIK 0001413350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,428,920 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.54 to $2.55 inclusive. Read SEC document |
| December 20, 2021 Filed Dec 21, 2021 16:25 UTC |
Neylan John F.See Remarks
|
SaleCommon Stock | 358 | $2.62 | $938.00 |
DisclosureSEC source: 0001601485-21-000091 · wf-form4_164012191372345.xml · nonDerivative · entry 1 Neylan John F. · CIK 0001640447 · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 35,136 F1 · kind: The shares reported in this Form 4 were sold pursuant to a 10b5-1 trading plan adopted on March 18, 2021 by the reporting person solely to satisfy tax or other government withholding obligations in connection with the vesting of Restricted Stock Awards ("RSAs") granted by the Issuer. Read SEC document |
| December 20, 2021 Filed Dec 22, 2021 21:06 UTC |
Venkatesan JayDirector · See Remarks
|
PurchaseCommon Stock | 3,527 | $2.54 | $8,975.86 |
DisclosureSEC source: 0001601485-21-000093 · wf-form4_164020718382276.xml · nonDerivative · entry 1 Venkatesan Jay · CIK 0001413350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,362,013 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.52 to $2.55 inclusive. Read SEC document |
| December 17, 2021 Filed Dec 20, 2021 23:44 UTC |
Venkatesan JayDirector · See Remarks
|
PurchaseCommon Stock | 13,742 | $2.54 | $34,958.27 |
DisclosureSEC source: 0001601485-21-000089 · wf-form4_164004385539278.xml · nonDerivative · entry 2 Venkatesan Jay · CIK 0001413350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,358,486 F2 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.50 to $2.55 inclusive. Read SEC document |
| December 16, 2021 Filed Dec 20, 2021 23:44 UTC |
Venkatesan JayDirector · See Remarks
|
PurchaseCommon Stock | 27,883 | $2.55 | $70,992.91 |
DisclosureSEC source: 0001601485-21-000089 · wf-form4_164004385539278.xml · nonDerivative · entry 1 Venkatesan Jay · CIK 0001413350 · Director · See Remarks 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,344,744 F1 · price: The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.53 to $2.55 inclusive. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.